Study of Chiglitazar Compare With Placebo in Type 2 Diabetes Patients
Clinical trial NCT02121717 · COMPLETED
Trial details
- NCT number
- NCT02121717
- Sponsor
- Chipscreen Biosciences, Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2017-11-01
- Enrollment
- 535
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.